A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

  • Sara E. Kochanny
  • , Francis P. Worden
  • , Douglas R. Adkins
  • , Dean W. Lim
  • , Julie E. Bauman
  • , Stephanie A. Wagner
  • , Ryan J. Brisson
  • , Theodore G. Karrison
  • , Walter M. Stadler
  • , Everett E. Vokes
  • , Tanguy Y. Seiwert

Research output: Contribution to journal › Article › peer-review

28   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science